This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to create new, targeted grant authorities administered by the Department of Justice (through the Bureau of Justice Assistance) to address fentanyl poisonings at the local level. It establishes programs aimed at (1) disrupting unlawful drug sales that use social media, (2) funding nonprofit public-awareness efforts about fentanyl dangers, and (3) equipping and training law enforcement to reduce officer exposure to fentanyl.
The measure matters because it channels federal crime‑control dollars specifically toward enforcement and education rather than harm-reduction services. The statutory language prescribes eligible uses, imposes a statutory prohibition on certain harm‑reduction purchases in the nonprofit grant stream (while permitting naloxone), and amends the Act to reserve funding for these new programs—shaping how local agencies and nonprofits can spend federal dollars on drug‑poisoning prevention activities.
At a Glance
What It Does
The bill authorizes three grant programs administered by the Attorney General through the Bureau of Justice Assistance, each established to combat fentanyl poisonings through: (a) proactive local law‑enforcement programs aimed at unlawful sales via social media; (b) nonprofit-run public education and awareness campaigns; and (c) procurement and training to protect officers from fentanyl exposure. The Attorney General must consult with the Secretary of Health and Human Services when awarding grants.
Who It Affects
State and local law enforcement agencies seeking federal support for investigations, schools and clinicians targeted by outreach and training components, and 501(c)(3) nonprofits that design public‑education campaigns. Indirectly affected stakeholders include parents, students, and first‑responders who will be the audience for funded education and training activities.
Why It Matters
By statute‑directing federal grant dollars toward enforcement and awareness while excluding many harm‑reduction supplies from one grant stream, the bill reshapes local program design incentives and narrows the universe of federally supported interventions against fentanyl poisonings.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill inserts a new section into the Omnibus Crime Control and Safe Streets Act to create three discrete grant authorities. The first authority funds state and local law enforcement to plan, design, establish, or operate locally based proactive programs that target the unlawful sale, marketing, or distribution of controlled substances using social media platforms.
The statute explicitly authorizes programs that prioritize arrest of individuals who use social media to sell drugs and that provide education and training (including online materials) for school personnel, clinicians, and the public. Agencies seeking these grants must apply to the Attorney General in the form and with the information the Attorney General reasonably requires.
The second authority funds nonprofit organizations to design, establish, and operate public education and awareness campaigns about the dangers of fentanyl. The bill enumerates permissible uses: transporting bereaved family members to speak at events; creating and distributing educational content (documentaries, pamphlets, infographics); offering counseling or mentorship to people who lost friends or family; and providing naloxone or overdose reversal education and training.
Crucially, the statute lists an explicit prohibition: grant funds cannot buy traditional harm‑reduction supplies—examples given include substance‑testing kits, syringes, safer‑smoking kits, or written materials on safer injection—while allowing naloxone and its administration supplies and training. The statute defines eligible nonprofit recipients as organizations exempt under section 501(c)(3) of the Internal Revenue Code and also caps individual grants under this subsection at $50,000.The third authority focuses on protecting law enforcement officers from fentanyl exposure on duty.
It allows grants to procure and distribute detection and overdose‑reversal equipment—specified examples include fentanyl test strips, field‑portable ion mobility spectrometers, naloxone, and naloxone administration supplies—and to provide training to officers in the use of that equipment. Across the three grant streams the Attorney General is required to consult with HHS.
Finally, the bill amends the Act’s reserved‑funds provision to earmark federal dollars for these new authorities (statutory allocations are set out in the amendment).
The Five Things You Need to Know
The bill requires the Attorney General, acting through the Bureau of Justice Assistance, to consult with the Secretary of Health and Human Services when awarding grants under all three programs.
One grant stream explicitly authorizes programs that prioritize arrest of individuals who use social media platforms to unlawfully sell, market, or distribute controlled substances.
Nonprofit education grants are limited to organizations that qualify under section 501(c)(3) and are capped at a maximum award of $50,000 per grant.
The nonprofit grant language specifically forbids use of funds to purchase many common harm‑reduction supplies (for example: test kits, syringes, safer‑smoking kits, and written safer‑injection materials) but allows purchase of naloxone and naloxone training/supplies.
The amendment to the Omnibus Crime Control and Safe Streets Act reserves dedicated funding for these authorities by adding three line items into the Act’s reserved‑funds provision.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the bill’s commonly used name, the “Combatting Fentanyl Poisonings Act of 2025.” This is formal language that enables citation and appears at the head of the statute.
Grants to target unlawful social‑media drug sales
Authorizes DOJ/BJA to award grants to state and local law enforcement to plan and operate proactive programs focused on stopping controlled‑substance sales that use social media platforms. The provision expressly authorizes prioritizing arrests of individuals who use social platforms to sell drugs and includes education and training for school staff, clinicians, and the public (including online resources). The head of the applying agency must submit an application to the Attorney General with requested information, making the award process discretionary and subject to federal application requirements.
Nonprofit public‑awareness grants (with restricted uses)
Creates a grant program for 501(c)(3) nonprofits to run public education and awareness campaigns about fentanyl dangers, listing allowable activities such as transporting family speakers, producing educational media, offering counseling/mentoring, and providing naloxone training and supplies. It draws a bright line on ineligible expenditures by barring typical harm‑reduction supplies (testing kits, sterile injection supplies, safer‑smoking kits, related paraphernalia, and written safer‑injection guidance), while permitting naloxone purchases and training. The section caps individual awards under this stream at $50,000 and defines eligible nonprofits by reference to the Internal Revenue Code.
Grants to protect officers from fentanyl exposure
Authorizes grants to equip and prepare officers at risk of fentanyl exposure by procuring detection/testing and overdose‑reversal equipment and providing training. The text names examples—fentanyl test strips, field‑portable ion mobility spectrometers, naloxone, and naloxone administration supplies—and ties funding to training in use of that equipment, signaling an operational focus on both tools and competency.
Reserved funds allocated for the new programs
Modifies the Act’s reserved funds clause to insert three dedicated line items for the new authorities. The amendment adds statutory earmarks specifically for the social‑media law‑enforcement grants, the nonprofit awareness grants, and the officer‑protection grants, thereby directing Congress’ appropriation priorities within the larger grant formula framework of the Act.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and local law enforcement agencies — receive federal support to develop targeted investigations, purchase detection/overdose‑reversal equipment, and train officers for fentanyl exposure risks, lowering out‑of‑pocket costs for those operational needs.
- 501(c)(3) nonprofit organizations focused on prevention and public education — gain a dedicated federal funding source to run awareness campaigns, produce educational content, and offer bereavement counseling and speaker programs (subject to the statutory cap).
- School personnel, clinicians, parents, and community audiences — stand to receive funded education and online training about fentanyl risks and methods often used to market drugs on social media, increasing community awareness and potential early intervention.
- Families of overdose victims — the bill explicitly funds travel for bereaved family members to participate in outreach events, creating a funded channel for survivor voices in public campaigns.
- Law enforcement officers — receive equipment and training grants intended to reduce on‑duty fentanyl exposure risks and to ensure officers have naloxone and know how to use it.
Who Bears the Cost
- Nonprofit organizations seeking to use federal funds for harm‑reduction services — the statute forbids use of the nonprofit grants to buy many common harm‑reduction supplies, forcing those organizations to cover those costs from other sources or forgo them.
- Federal appropriations for other programs within the Omnibus Crime Control Act — the bill amends the reserved funds clause to earmark money for these streams, which can reduce flexible funding available for other grants unless Congress increases overall appropriations.
- Local jurisdictions that prefer harm‑reduction approaches — may face a policy mismatch between federally funded options and locally preferred interventions, effectively shifting the program mix toward enforcement and education.
- State and local law enforcement agencies required to comply with grant application and reporting requirements — administrative burdens (applications, training, procurement compliance) will fall on agencies without a guaranteed award, and ongoing maintenance of procured equipment may create future costs.
Key Issues
The Core Tension
The central tension is between targeting immediate enforcement and awareness (and equipping officers for safety) versus supporting broad harm‑reduction strategies that public‑health experts argue prevent overdoses. The bill solves one problem—directing federal crime‑control resources toward fentanyl threats—while constraining another—non‑law‑enforcement harm‑reduction interventions—leaving jurisdictions to choose between federally funded enforcement/education and locally funded public‑health approaches.
The bill creates targeted federal funding pathways but attaches programmatic limits that will shape local practice. The nonprofit stream’s explicit ban on a wide range of harm‑reduction supplies (test kits, syringes, safer‑smoking kits, written safer‑injection materials) while allowing naloxone creates a mixed policy signal: it funds overdose reversal but restricts interventions that public‑health evidence sometimes treats as prevention.
That restriction raises operational questions for nonprofits that currently bundle education, naloxone distribution, and harm‑reduction services but would have to segregate activities or identify alternative funding for the prohibited items.
The law enforcement-focused grants emphasize disruption and arrest of social‑media‑based sellers and authorize procurement of certain testing and detection tools. That focus increases investigative capacity but may also incentivize enforcement strategies that prioritize supply‑side arrests over demand‑reduction or treatment linkages.
The bill requires consultation with HHS, but the statutory text does not define evaluation metrics or reporting requirements to measure whether the funded activities actually reduce fatalities, increase treatment uptake, or change online drug‑market dynamics. The reserved funding line items create near‑term budget certainty only if Congress appropriates the sums; otherwise, the authorizations alone do not guarantee sustained funding.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.